Animal Parasiticides Market Report 2026

Animal Parasiticides Market Overview

• Animal Parasiticides market size has reached to $10.13 billion in 2025 • Expected to grow to $14.53 billion in 2030 at a compound annual growth rate (CAGR) of 7.4% • Growth Driver: Rising Zoonotic Diseases Fuel Growth In The Market • Market Trend: Innovative Combination Therapies Delivering Comprehensive And Convenient Parasite Protection • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Animal Parasiticides Market?

Animal parasiticides refer to chemical or biological agents designed to prevent, control, and eliminate parasitic infestations in livestock, companion animals, and other domesticated species. They are used for protecting animals from external and internal parasites, improving animal health, and enhancing productivity in agricultural and veterinary settings. The main types of animal parasiticides are endoparasticides, ectoparasiticides, and endectocides. Endoparasiticides are medications designed to eliminate internal parasites, such as worms, that reside within an animal's body. The different livestock are swine, poultry, ovine, bovine, equine, canine, and feline and are used by end users such as veterinary clinics and hospitals, animal farms, and home care settings.

What Is The Animal Parasiticides Market Growth Forecast?

The animal parasiticides market size is expected to see strong growth in the next few years. It will grow to $14.53 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to technological advancements in parasiticides, growing companion animal market, increasing regulatory support for animal health, rising adoption of preventive healthcare, expansion of veterinary services in emerging regions. Major trends in the forecast period include rising incidence of parasitic infestations in livestock, adoption of novel veterinary parasiticides formulations, increasing awareness of animal health and welfare, growth in companion animal ownership and care, integration of preventive healthcare practices in veterinary medicine.

Global Animal Parasiticides Market Segmentation

1) By Type: Endoparasticides, Ectoparasiticides, Endectocides 2) By Livestock: Swine, Poultry, Ovine, Bovine, Equine, Canine, Feline 3) By End User: Veterinary Clinics And Hospitals, Animal Farms, Home Care Settings Subsegments: 1) By Endoparasiticides: Anthelmintics, Antiprotozoals, Anticestodals 2) By Ectoparasiticides: Insecticides, Acaricides, Larvicides 3) By Endectocides: Macrocyclic Lactones, Imidazothiazoles, Spinosyns

What Is The Driver Of The Animal Parasiticides Market?

The increase in the prevalence of zoonotic diseases is expected to propel the growth of the animal parasiticides market going forward. Zoonotic diseases are infectious diseases that can be transmitted between animals and humans caused by bacteria, viruses, parasites, or fungi. The number of zoonotic diseases is increasing due to factors including climate change, antibiotic resistance, poor sanitation, and hygiene. Animal parasiticides help prevent zoonotic diseases by controlling parasites that act as vectors or reservoirs for disease transmission between animals and humans. For instance, in December 2024, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, 148,181 human cases of campylobacteriosis, up from 139,225 in 2022, alongside increases in salmonellosis and STEC infections, reflecting a broader upward trend in zoonotic illnesses. Veterinary Services Market supports this trend by delivering essential preventive care, diagnostics, and treatment to animals, reducing disease transmission risk through vaccination, surveillance, and client education. Therefore, the increase in the prevalence of zoonotic diseases is driving the growth of the animal parasiticides industry.

Key Players In The Global Animal Parasiticides Market

Major companies operating in the animal parasiticides market are Merck & Co. Inc., Bayer AG, Sanofi SA, Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Inc., Ceva Sante Animale S.A., Virbac SA, Dechra Pharmaceuticals plc, Phibro Animal Health Corporation, Vetoquinol SA, Norbrook Laboratories Limited, Neogen Corporation, Indian Immunologicals Ltd., Krka dd Novo Mesto, Bimeda Inc., The Chanelle Group, ECO Animal Health Group plc, Zydus Animal Health and Investments Ltd., Kyoritsu Seiyaku Corporation

Global Animal Parasiticides Market Trends and Insights

Major companies operating in the animal parasiticides market are focusing on developing innovative combination therapies and advanced oral formulations to gain a competitive advantage and address the growing need for broad-spectrum parasite control. combination therapies and advanced oral formulations refer to products that combine multiple active ingredients in a single, easy-to-administer dosage form to provide comprehensive and long-lasting protection against a wide range of parasites. For instance, in January 2025, Elanco Animal Health Incorporated, a US-based global animal health company, launched Credelio Quattro, an innovative oral combination therapy parasiticide designed to deliver broad-spectrum parasite protection in the global animal parasiticides market. Credelio Quattro combines four active ingredients, lotilaner, moxidectin, praziquantel, and pyrantel, in a single monthly chewable tablet to protect dogs against fleas, ticks, heartworms, roundworms, hookworms, and tapeworms, expanding beyond traditional single-agent treatments. This combination therapy enhances efficacy by targeting multiple parasite classes with different mechanisms of action, simplifying parasite management for veterinarians and pet owners and improving treatment compliance. With rapid onset of action and extended coverage, Credelio Quattro supports both preventive and therapeutic applications, helping to reduce parasite resistance development while offering comprehensive protection in one convenient dosage form.

What Are Latest Mergers And Acquisitions In The Animal Parasiticides Market?

In April 2024, Merck & Co. Inc., a US–based animal health pharmaceutical company, acquired Elanco Animal Health Incorporated’s Aqua Business for approximately USD 1.3 billion. With this acquisition, Merck Animal Health aimed to strengthen and expand its aquaculture portfolio by adding established parasiticide and health management solutions for farmed fish, thereby enhancing its position in the global aquaculture animal health market. Elanco Animal Health Incorporated is a US-based an animal health business unit that specializes in developing and commercializing aquaculture products, including parasiticides for sea lice control, vaccines, and other health solutions for farmed fish species.

Regional Outlook

North America was the largest region in the animal parasiticides market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Animal Parasiticides Market?

The animal parasiticides market consists of sales of injectable dewormers, feed additives and medicated pellets, sprays and pour-ons, and macrocyclic lactones. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.